Orchard Therapeutics, a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patien...
Bristol-Myers Squibb Company has announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...
Bristol-Myers Squibb Company and Boston Medical centre, a private, not-for-profit, academic medical centre has announced...
Merck has launched the latest evolution in sterility testing devices, the Steritest™ NEO device, which provides sa...
Eli Lilly and Company has announced an agreement with Hydra Biosciences to acquire all assets related to Hydra's pre-cli...
Eli Lilly and Company has announced that Taltz® (ixekizumab) met the primary and all major secondary endpo...
Molecular manufacturing technology company, Zymergen has announced that it has raised over $400 million in Series C fund...
Growth in healthcare adoption has benefited the API market immensely. There is greater focus on accessibility ...
Psychiatric disorders’ many complexities have stymied scientists looking for clear genetic culprits. But a new gia...
Generex Biotechnology Corporation has announced that the FDA had reviewed the company’s investigational new drug (...
Cambridge Heartwear, a medical provider of low-cost, next-generation wearable heart monitors that uses artificial i...
Amgen and Direct Relief today announced a joint initiative in which Direct Relief will distribute $93 million ...
Health Canada is warning that all products manufactured by Professional Botanicals Inc. may pose serious healt...
Merck, known as MSD outside the United States and Canada, and Instituto Butantan, Sao Paulo, Brazil, a non-profit produc...
A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerabilit...
Most contaminants are invisible to the naked eye. Micro-organisms are fairly small, they pose a severe threat to the saf...
Berkeley Lights, Inc. and Novo Nordisk have announced that Novo Nordisk has purchased the Beacon Optofluidic platform to...
The Menarini Group has recently reached an agreement with Melinta Therapeutics to commercialize meropenem/vaborbactam in...
